Immediate Impact
54 standout
Citing Papers
EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
2024 Standout
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
2024 Standout
Works of E. Karpińska being referenced
Durability of virologic response, risk of de novo hepatocellular carcinoma, liver function and stiffness 2 years after treatment with ombitasvir/paritaprevir/ritonavir±dasabuvir±ribavirin in the AMBER, real‐world experience study
2018
Risk factors and dynamics of weight gain in patients after liver transplantation.
2009
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| E. Karpińska | 101 | 80 | 117 | 116 | 30 | 313 | |
| Wengui Li | 47 | 119 | 191 | 90 | 45 | 361 | |
| Yuxin Guo | 54 | 50 | 119 | 166 | 32 | 355 | |
| Yumin Zhu | 50 | 80 | 106 | 61 | 27 | 331 | |
| J. Rehage | 51 | 51 | 28 | 111 | 21 | 357 | |
| F. A. Lewis | 169 | 16 | 194 | 35 | 19 | 369 | |
| Hakan Aydın | 54 | 25 | 160 | 63 | 40 | 314 | |
| Yonghao Hu | 75 | 32 | 126 | 76 | 30 | 325 | |
| Koo Nagasawa | 177 | 29 | 212 | 97 | 33 | 336 | |
| Lili Li | 100 | 26 | 207 | 99 | 28 | 291 | |
| Narayan Ramamurthy | 158 | 58 | 48 | 72 | 23 | 302 |
All Works
Loading papers...